Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,851 | -2,735 | -18,490 | -14,293 | -9,860 |
| Depreciation Amortization | 13 | 8 | 475 | 399 | 284 |
| Accounts payable and accrued liabilities | -217 | -14 | -583 | 29 | -141 |
| Other Working Capital | -644 | -441 | 85 | 279 | 54 |
| Other Operating Activity | 374 | 111 | 1,041 | 310 | 361 |
| Operating Cash Flow | $-5,325 | $-3,071 | $-17,472 | $-13,276 | $-9,302 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -1 | -3 | -2 | -2 |
| Purchase Of Investment | N/A | N/A | -5,471 | -5,471 | -2,039 |
| Sale Of Investment | 3,050 | 3,050 | 18,400 | 13,650 | 11,150 |
| Investing Cash Flow | $3,049 | $3,049 | $12,926 | $8,177 | $9,109 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,532 | 3,532 | 6,551 | 6,515 | 2,284 |
| Other Financing Activity | -323 | -116 | -704 | -675 | -391 |
| Financing Cash Flow | $3,209 | $3,416 | $5,847 | $5,840 | $1,893 |
| Beginning Cash Position | 8,702 | 8,702 | 7,401 | 7,401 | 7,401 |
| End Cash Position | 9,635 | 12,096 | 8,702 | 8,142 | 9,101 |
| Net Cash Flow | $933 | $3,394 | $1,301 | $741 | $1,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,325 | -3,071 | -17,472 | -13,276 | -9,302 |
| Capital Expenditure | -1 | -1 | -3 | -2 | -2 |
| Free Cash Flow | -5,326 | -3,072 | -17,475 | -13,278 | -9,304 |